RISK STRATIFICATION OF HUMAN LEUKOCYTE ANTIGEN CLASS II DONOR SPECIFIC ANTIBODY POSITIVE PATIENTS BY IMMUNOGLOBULIN G SUBCLASSES

CH 29 : Michiko Taniguchi, Lorita M. Rebellato, Kimberly P. Briley, Carl E. Haisch, Paul Bolin, Nubia Banuelos, Judy Hopfield, Paul I. Terasaki, and Matthew J. Everly

Abstract

 Background: Human leukocyte antigen (HLA) antibodies are a major cause of graft loss in mismatched transplant recipients. However, the time to graft loss resulting from antibody induced injury is unpredictable. The unpredictable nature of antibodies may be related to the subclass of antibodies. In this study, HLA immunoglobulin G (IgG) subclasses were investigated to determine whether a unique IgG subclass composition could better identify those patients at eminent risk for graft loss. Methods: The serial serum samples from the 57 patients with post-transplant HLA class II donor specific antibodies (DSA) were tested for the three IgG subclasses (IgG1, IgG3, and IgG4). Results: IgG3 and IgG4 were highly prevalent in failed patients compared to functioning patients (82 % vs. 34%, 45% vs. 20%, respectively). IgG3 development showed a distinct subclass trend between failed and functioning patients with poor graft survival (log rank p=0.0006). IgG1 was almost equally abundant in both groups (100% and 97%, respectively). Of the 5 patterns of IgG subclass combinations observed, IgG1+3+ showed the strongest association with graft failure (hazard ratio 3.14, p=0.007). Conclusion: Patients with IgG3 subclass HLA DSA showed lower graft survival. Posttransplant monitoring for IgG subclasses rather than total IgG monitoring may identify patients at risk for graft failure.